Vasculitis syndromes are rare yet devastating clinically to patients and families. At Cedars-Sinai, we have initiated a multidisciplinary vasculitis program in conjunction with the Vasculitis Clinical Research Consortium, the international group of researchers who study the epidemiology, genetics and environmental risk of these diseases, as well as innovative therapies.

Program Interactions in Vasculitis

  • Stanford University — Cornelia Weyand, MD
  • Cleveland Clinic — Carol Langford, MD, MHS
  • University of Pennsylvania — Peter Merkel, MD, MPH
  • Massachusetts General Hospital — John Stone, MD, MPH